Platelet Glycoprotein IV Deficiency: Clinical Trials

2 trials for Platelet Glycoprotein IV Deficiency, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 1, Unknown 1

Follow Platelet Glycoprotein IV Deficiency: new trials by email Literature Review of Platelet Glycoprotein IV Deficiency trials Research Report on Platelet Glycoprotein IV Deficiency

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Empagliflozin on Body Composition and Ketones
Empagliflozin 10 MG, Hypoglycemics Oral - Diabetes Mellitus, Fat; Intolerance, Pancreas
Phase 4UnknownSeoul National University Bundang Hospital2002018-08-012023-08-14
Impact of Liraglutide 3.0 on Body Fat Distribution
Liraglutide, Placebo - Obesity, Visceral, Cardiovascular Diseases
Phase 4CompletedUniversity of Texas Southwestern Medical Center2352017-01-012021-11-19

Narrower conditions

Cardiovascular Diseases (1)  ·  Diabetes Mellitus (1)  ·  Lipid Metabolism Disorders (1)  ·  Obesity (1)  ·  Obesity, Abdominal (1)

Broader conditions

Metabolic Diseases (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Body Weight (1)  ·  Endocrine System Diseases (1)  ·  Glucose Metabolism Disorders (1)  ·  Nutrition Disorders (1)  ·  Overnutrition (1)  ·  Overweight (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Interventions

Hypoglycemic Agents (1)  ·  Liraglutide (1)  ·  Sodium Chloride (1)  ·  Sodium-Glucose Transporter 2 Inhibitors (1)  ·  empagliflozin (1)

Sponsors

Seoul National University Bundang Hospital (1)  ·  University of Texas Southwestern Medical Center (1)

Countries

South Korea (1)  ·  United States (1)

Top investigators

Parag Joshi, MD (1)  ·  Soo N Lim, MD, PHD (1)

Results publications

PMID 34358471